» Authors » Bastian Zinnhardt

Bastian Zinnhardt

Explore the profile of Bastian Zinnhardt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 503
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giorgio J, Soleimani-Meigooni D, Janabi M, Baker S, Chen X, Toueg T, et al.
J Nucl Med . 2025 Mar; PMID: 40049743
Synaptic density imaging with PET is a relatively new approach to monitoring synaptic injury in neurodegenerative diseases. However, there are remaining technical and clinical questions, including questions on reference region...
2.
Roll W, Bauer J, Dik A, Mueller C, Backhaus P, Rauber S, et al.
J Neurol . 2024 Mar; 271(6):3653-3659. PMID: 38472399
No abstract available.
3.
Gallus M, Roll W, Dik A, Barca C, Zinnhardt B, Hicking G, et al.
Sci Adv . 2023 Jun; 9(23):eabq7595. PMID: 37294768
Autoimmune limbic encephalitis (ALE) presents with new-onset mesial temporal lobe seizures, progressive memory disturbance, and other behavioral and cognitive changes. CD8 T cells are considered to play a key role...
4.
Pezzini F, Pisani A, Mazziotti V, Marastoni D, Tamanti A, Borroni E, et al.
Int J Mol Sci . 2023 Feb; 24(4). PMID: 36835179
Intrathecal inflammation plays a key role in the pathogenesis of multiple sclerosis (MS). To better elucidate its relationship with peripheral inflammation, we investigated the correlation between cerebrospinal fluid (CSF) and...
5.
Schulte-Mecklenbeck A, Zinnhardt B, Muller-Miny L, Haessner S, Meyer Zu Horste G, Wiendl H, et al.
J Immunol Methods . 2023 Jan; 514:113428. PMID: 36690066
No abstract available.
6.
Barca C, Foray C, Zinnhardt B, Winkeler A, Herrlinger U, Grauer O, et al.
Cancers (Basel) . 2022 Jul; 14(13). PMID: 35804911
Glioblastoma is the most common primary brain tumor, highly aggressive by being proliferative, neovascularized and invasive, heavily infiltrated by immunosuppressive glioma-associated myeloid cells (GAMs), including glioma-associated microglia/macrophages (GAMM) and myeloid-derived...
7.
Schwake M, Muther M, Bruns A, Zinnhardt B, Warneke N, Holling M, et al.
Cancers (Basel) . 2022 Feb; 14(3). PMID: 35158809
Background: Concepts improving local tumor control in high-grade glioma (HGG) are desperately needed. The aim of this study is to report an extended series of cases treated with a combination...
8.
Foray C, Barca C, Winkeler A, Wagner S, Hermann S, Schafers M, et al.
J Nucl Med . 2022 Feb; 63(9):1386-1393. PMID: 35115369
Glioma-associated microglia and macrophages (GAMMs) are key players in creating an immunosuppressive microenvironment. They can be efficiently targeted by inhibiting the colony-stimulating factor 1 receptor (CSF-1R). We applied noninvasive PET/CT...
9.
Barca C, Kiliaan A, Wachsmuth L, Foray C, Hermann S, Faber C, et al.
J Nucl Med . 2022 Feb; 63(9):1408-1414. PMID: 35115368
Studies on colony-stimulating factor 1 receptor (CSF-1R) inhibition-induced microglia depletion indicated that inhibitor withdrawal allowed the renewal of the microglia compartment via repopulation and resolved the inflammatory imbalance. Therefore, we...
10.
Barca C, Griessinger C, Faust A, Depke D, Essler M, Windhorst A, et al.
Pharmaceuticals (Basel) . 2022 Jan; 15(1). PMID: 35056071
Radioligand theranostics (RT) in oncology use cancer-type specific biomarkers and molecular imaging (MI), including positron emission tomography (PET), single-photon emission computed tomography (SPECT) and planar scintigraphy, for patient diagnosis, therapy,...